AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a large decline in short interest during the month of July. As of July 31st, there was short interest totalling 11,600 shares, a decline of 78.2% from the July 15th total of 53,100 shares. Based on an average daily trading volume, of 4,000 shares, the short-interest ratio is currently 2.9 days.

AstraZeneca Stock Performance

Shares of AZNCF stock remained flat at $165.60 on Monday. The stock had a trading volume of 286 shares, compared to its average volume of 3,099. AstraZeneca has a 12 month low of $118.16 and a 12 month high of $165.60. The company’s fifty day moving average price is $157.00 and its 200-day moving average price is $144.68.

AstraZeneca Cuts Dividend

The company also recently announced a dividend, which will be paid on Monday, September 9th. Shareholders of record on Friday, August 9th will be given a dividend of $1.00 per share. The ex-dividend date is Wednesday, August 7th. AstraZeneca’s dividend payout ratio is presently 343.14%.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in AstraZeneca stock. Kennedy Capital Management LLC acquired a new stake in AstraZeneca PLC (OTCMKTS:AZNCF) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. Institutional investors and hedge funds own 40.87% of the company’s stock.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.